Artículos de revistas
Inhibition Of Cyp21a2 Enzyme Activity Caused By Novel Missense Mutations Identified In Brazilian And Scandinavian Patients
Registro en:
Journal Of Clinical Endocrinology And Metabolism. , v. 93, n. 6, p. 2416 - 2420, 2008.
0021972X
10.1210/jc.2007-2594
2-s2.0-45149125300
Autor
Soardi F.C.
Barbaro M.
Lau I.F.
Lemos-Marini S.H.V.
Baptista M.T.M.
Guerra Jr. G.
Wedell A.
Lajic S.
De Mello M.P.
Institución
Resumen
Background: Most patients with 21-hydroxylase deficiency carry CYP21A1P-derived mutations, but an increasing number of novel and rare mutations have been reported in disease-causing alleles. Objective: Functional effects of three novel (p.G56R, p.L107R, p.L142P) and one recurrent (p.R408C) CYP21A2 mutations were investigated. The degree of enzyme impairment caused by p.H62L alone or combined to p.P453S was also analyzed. Design: The study included 10 Brazilian and two Scandinavian patients. To determine the deleterious role of each mutant protein, in vitro assays were performed in transiently transfected COS-1 cells. For a correct genotype-phenotype correlation, the enzymatic activities were evaluated toward the two natural substrates, 17-hydroxyprogesterone and progesterone. Results: Low levels of residual activities obtained for p.G56R, p.L107R, p.L142P, and p.R408C mutants classified them as classical congenital adrenal hyperplasia mutations, whereas the p.H62L showed an activity within the range of nonclassical mutations. Apparent kinetic constants for p.H62L confirmed the nonclassical classification as the substrate binding capacity was within the same magnitude for mutant and normal enzymes. A synergistic effect was observed for the allele bearing the p.H62L+p.P453S combination because it caused a significant reduction in the enzymatic activity. Conclusions: We describe the functional analysis of five rare missense mutations identified in Brazilian and Scandinavian patients. The p.G56R, p.L107R, and p.L142P are reported for the first time. Most probably these novel mutations are closer to null than the p.I172N, but for the p.G56R, that might not be the case, and the p.H62L is definitely a nonclassical mutation. Copyright © 2008 by The Endocrine Society. 93 6 2416 2420 New, M.I., Inborn errors of adrenal steroidogenesis (2003) Mol Cel Endocrinol, 211, pp. 75-83 Lajic, S., Clauin, S., Vexiau, P., Blanche, H., Bellanne-Chantelot, C., Wedell, A Novel mutations in CYP21 detected in individuals with hyperandrogenism (2002) J Clin Endocrinol Metab, 87, pp. 2824-2829 White, P.C., Grossberger, D., Onufer, B.J., Chaplin, D.D., New, M.I., Dupont, B., Strominger, J.L., Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man (1985) Proc Natl Acad Sci USA, 82, pp. 1089-1093 Yang, Z., Mendoza, A.R., Welch, T.R., Zipf, W.B., Yu, C.Y., Modular variations of the human major histocompatibility complex class III genes for serine/threonine kinase RP, complement component C4, steroid 21-hydroxylase CYP21, and tenascin TNX (the RCCX module). A mechanism for gene deletions and disease associations (1999) J Biol Chem, 274, pp. 12147-12156 White, P.C., Speiser, P.W., Congenital adrenal hyperplasia due to 21-hydroxylase deficiency (2000) Endocr Rev, 21, pp. 245-291 Krone, N., Riepe, F.G., Partsch, C.J., Vorhoff, W., Bramswig, J., Sippell, W.G., Three novel point mutations of the CYP21 gene detected in classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (2006) Exp Clin Endocrinol Diabetes, 114, pp. 111-117 Barbaro, M., Baldazzi, L., Balsamo, A., Lajic, S., Robins, T., Barp, L., Pirazzoli, Wedell, A., Functional studies of two novel and two rare mutations in the 21-hydroxylase gene (2006) J Mol Med, 84, pp. 521-528 Billerbeck, A.E., Mendonca, B.B., Pinto, E.M., Madureira, G., Arnhold, I.J., Bachega, T.A., Three novel mutations in CYP21 gene in Brazilian patients with the classical form of 21-hydroxylase deficiency due to a founder effect (2002) J Clin Endocrinol Metab, 87, pp. 4314-4317 Sambrook, J., Fritsch, E.F., Maniatis, T.E., (1989) Molecular cloning, a laboratory manual, , New York: Cold Spring Harbor Lau, I.F., Soardi, F.C., Lemos-Marini, S.H., Guerra Jr, G., Baptista, M.T., De Mello, M.P., H28+C insertion in the CYP21 gene: A novel frameshift mutation in Brazilian patient with the classical form of 21-hydroxylase deficiency (2001) J Clin Endocrinol Metab, 86, pp. 5877-5880 Higashi, Y., Yoshioka, H., Yamane, M., Gotoh, O., Fujii-Kuriyama, Y., Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: A pseudogene and a genuine gene (1986) Proc Natl Acad Sci USA, 83, pp. 2841-2845 Nikoshkov, A., Lajic, S., Holst, M., Wedell, A., Luthman, H., Synergistic effect of partially inactivating mutations in steroid 21-hydroxylase deficiency (1997) J Clin Endocrinol Metab, 82, pp. 194-199 Lajic, S., Levo, A., Nikoshkov, A., Lundberg, Y., Partanen, J., Wedell, A., A cluster of missense mutations at Arg356 of human steroid 21-hydroxylase may impair redox partner interaction (1997) Hum Genet, 99, pp. 704-709 Robins, T., Barbaro, M., Lajic, S., Wedell, A., Not all amino acid substitutions of the common cluster E6 mutation in CYP21 cause congenital adrenal hyperplasia (2005) J Clin Endocrinol Metab, 90, pp. 2148-2153 Williams, P.A., Cosme, J., Sridhar, V., Johnson, E.F., McRee, D.E., Microsomal cytochrome P450 2C5: Comparison to microbial P450s and unique features (2000) J Inorg Biochem, 81, pp. 183-190 Robins, T., Carlsson, J., Sunnerhagen, M., Wedell, A., Persson, B., Molecular model of human CYP21 based on mammalian CYP2C5: Structural features correlate with clinical severity of mutations causing congenital adrenal hyperplasia (2006) Mol Endocrinol, 20, pp. 2946-2964 Krone, N., Braun, A., Roscher, A.A., Knorr, D., Schwarz, H.P., Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany (2000) J Clin Endocrinol Metab, 85, pp. 1059-1065 Wester, M.R., Johnson, E.F., Marques-Soares, C., Dansette, P.M., Mansuy, D., Stout, C.D., Structure of a substrate complex of mammalian cytochrome P450 2C5 at 2.3 A resolution: Evidence for multiple substrate binding modes (2003) Biochemistry, 42, pp. 6370-6379 Pinto, G., Tardy, V., Trivin, C., Thalassinos, C., Lortat-Jacob, S., Nihoul-Fekete, C., Morel, Y., Brauner, R., Follow-up of 68 children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Relevance of genotype for management (2003) J Clin Endocrinol Metab, 88, pp. 2624-2633 Menassa, R., Tardy, V., Despert, F., Bouvattier-Morel, C., Brossier, J.P., Cartigny, M., Morel, Y., p.H62L, a rare mutation of the CYP21 gene identified in two forms of 21-hydroxylase deficiency (2008) J Clin Endocrinol Metab, 93, pp. 1901-1908